These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 35464443)
21. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters. Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438 [TBL] [Abstract][Full Text] [Related]
22. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19? Hu Y; Liu L; Lu X Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001 [TBL] [Abstract][Full Text] [Related]
23. Advances in Targeting ACE2 for Developing COVID-19 Therapeutics. Suvarnapathaki S; Chauhan D; Nguyen A; Ramalingam M; Camci-Unal G Ann Biomed Eng; 2022 Dec; 50(12):1734-1749. PubMed ID: 36261668 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease. Lebek S; Tafelmeier M; Messmann R; Provaznik Z; Schmid C; Maier LS; Birner C; Arzt M; Wagner S Eur J Heart Fail; 2020 Dec; 22(12):2248-2257. PubMed ID: 33017071 [TBL] [Abstract][Full Text] [Related]
25. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587 [TBL] [Abstract][Full Text] [Related]
26. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review. Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
28. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
29. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection. Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323 [TBL] [Abstract][Full Text] [Related]
31. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Chen L; Li X; Chen M; Feng Y; Xiong C Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090 [TBL] [Abstract][Full Text] [Related]
32. Effects of acute severe acute respiratory syndrome coronavirus 2 infection on male hormone profile, Huang Z; Do DV; Beh D; Lee CK; Yan B; Foo R; Tambyah PA F S Sci; 2022 Feb; 3(1):29-34. PubMed ID: 34841282 [TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host-virus interaction studies. Tang WF; Tran AT; Wang LY; Horng JT Biomed J; 2023 Apr; 46(2):100587. PubMed ID: 36849044 [TBL] [Abstract][Full Text] [Related]
34. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients. Huang X; He C; Hua X; Kan A; Sun S; Wang J; Li S Int J Biol Sci; 2020; 16(13):2464-2476. PubMed ID: 32760213 [TBL] [Abstract][Full Text] [Related]
35. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. Achom A; Das R; Pakray P Comput Biol Med; 2022 Dec; 151(Pt A):106050. PubMed ID: 36334362 [TBL] [Abstract][Full Text] [Related]
36. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19. Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S J Genet; 2021; 100(1):. PubMed ID: 33707363 [TBL] [Abstract][Full Text] [Related]
37. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Pan F; Xiao X; Guo J; Song Y; Li H; Patel DP; Spivak AM; Alukal JP; Zhang X; Xiong C; Li PS; Hotaling JM Fertil Steril; 2020 Jun; 113(6):1135-1139. PubMed ID: 32482249 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors. Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736 [TBL] [Abstract][Full Text] [Related]
39. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century. Asrani P; Hasan GM; Sohal SS; Hassan MI OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573 [TBL] [Abstract][Full Text] [Related]
40. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure. Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]